Made With Uberflip Content Marketing

Biotech startups

Find out the latest in biopharma innovation here as we explore opportunities for investing in early stage biotech startups.

  • Health tech innovators pitch business ideas to expert panel at BIO-Europe Spring®

    Health tech innovators pitch business ideas to expert panel at BIO-Europe Spring®

    The buzz steadily grew as the Health Tech Competition got underway on the last day of BIO-Europe Spring® March 22 in Barcelona. As delegates filed into the competition room, the energy was...

    Read
  • BIO-Europe Spring® 2017: Sofinnova chairman discusses entrepreneurial culture change in biotech5:47

    BIO-Europe Spring® 2017: Sofinnova chairman discusses entrepreneurial culture change in biotech

    Antoine Papiernik is the chairman of Paris-based Sofinnova Partners, a venture capital firm that invests in startups and spinout biotech companies primarily in Europe. He spoke with Luke Timmerman, th

    Watch Video
  • Biotechs successfully navigate alternative paths to financing

    Biotechs successfully navigate alternative paths to financing

    Project awards, strategic venture funds and now crowd-funding offer alternatives to traditional venture funds for emerging biotech companies. Pfizer's new strategic fund or the well-established...

    Read
  • Startup Slam: Compelling pitch for Peptomyc takes the prize

    Startup Slam: Compelling pitch for Peptomyc takes the prize

    The third round of this fast-paced parade of presentations pitted 14 promising entrepreneurs in a winner-take-all competition. The reward includes tailored mentoring with the scientists and...

    Read
  • Report gives substance to fast-paced scientific discoveries in microbiome

    Report gives substance to fast-paced scientific discoveries in microbiome

    Guest post by Eric de La Fortelle, Venture Partner at Seventure Partners Microbes are everywhere, and apart from the occasional pathogen, they are a positive force for health maintenance. Indeed...

    Read
  • Stirring the Pot for Entrepreneurship in European Tech Transfer

    Stirring the Pot for Entrepreneurship in European Tech Transfer

    Guest post by Luke Timmerman, founder and editor of the Timmerman Report, and a regular contributor to Forbes and STAT News. The science in many parts of Europe is first-rate. No one disputes...

    Read
  • Why the connected patient is the killer app in the digital age of medicine

    Why the connected patient is the killer app in the digital age of medicine

    Guest article by Deb Kilpatrick, PhD, CEO at Evidation Health and Rich Milani, MD, FACC, FAHA, Chief Clinical Transformation Officer at Ochsner Health System If you search on the phrase “killer...

    Read
  • Top tips from investors on pitching your company at BioPharm America™

    Top tips from investors on pitching your company at BioPharm America™

    A group of seasoned biotech investors gathered this week at BioPharm America™ to meet with innovative biotech companies, and to participate in “The Perfect Pitch: Do you have what it takes to win...

    Read
  • Barcelona’s GP Pharm considers partnering key to international expansion

    Barcelona’s GP Pharm considers partnering key to international expansion

    Barcelona is an attractive location for business and trade, and has experienced a revival in the biopharma sector in recent years with the outsourcing of innovation from pharma companies to...

    Read
  • Barcelona biotech companies shine light on regional entrepreneurship

    Barcelona biotech companies shine light on regional entrepreneurship

    Investors are always on the lookout for innovative biotech startups, and the Catalonia, Spain biopharma cluster has plenty to offer in the way of innovation from among its member companies....

    Read
  • Who gets funded? Imaginative companies!

    Who gets funded? Imaginative companies!

    The biotech industry needs a new approach that approximates the type of disruption that Uber brought to transportation and Amazon and eBay brought to retail sales. Instead of embracing those lean...

    Read
  • UK Establishment upbeat about Brexit’s effect on British life science industry

    UK Establishment upbeat about Brexit’s effect on British life science industry

    Brexit may no longer be at the top of popular news, but it continues to be a key concern for biopharma companies in post-Brexit 2017. The sentiment of key players from the UK life sciences from a...

    Read
  • It’s all happening at Biotech Showcase™ Week

    It’s all happening at Biotech Showcase™ Week

    Guest post by Constantine Theodoropulos, President, GO Therapeutics Thankfully there is a holiday between now and Biotech Showcase™ Week in San Francisco (Jan 9–11), because we are going to need...

    Read
  • Inositec CEO on 2017 financing plans

    Inositec CEO on 2017 financing plans

    Inositec is developing innovative new drugs using its proprietary Inositune technology to adjust the properties of inositol phosphate analogs, says CEO Mattias Ivarsson. Read more » Related...

    Read
  • Digital Health Security: The Most Important Tradeoff Between Ease and Privacy

    Digital Health Security: The Most Important Tradeoff Between Ease and Privacy

    Guest post by Nicole Fisher, Founder & CEO at HHR Strategies, Inc., Forbes Contributor Wayne Gretzky always said it’s better to look where the puck is going, not where it is now. The introduction...

    Read
  • Thirteen young people bucking the odds, finding paths to break into biotech

    Thirteen young people bucking the odds, finding paths to break into biotech

    Guest post by Luke Timmerman, founder and editor of the Timmerman Report, and a regular contributor to Forbes and STAT News. Walking around San Francisco’s Union Square during biotech conference...

    Read
  • Digital Health: Smart Devices Were Just The Beginning

    Digital Health: Smart Devices Were Just The Beginning

    The connectivity that will be created by the convergence of computers and health will truly alter the way knowledge, technology and insights into the future revolutionize health care.

    Read
  • Cinfa outlines biosimilar development areas and deal opportunities

    Cinfa outlines biosimilar development areas and deal opportunities

    Cinfa Biotech's managing director, Ruediger Jankowsky, discusses the company's founding and focus on biosimilar drug development. Read more » Related Posts Sixth Element Capital outlines...

    Read
  • Biotechs scramble as public markets dry up, but can private equity help?

    Biotechs scramble as public markets dry up, but can private equity help?

    Does the slump in the IPO boom create a bigger pool of private capital to invest in drug development, or do emerging companies have their backs to the wall? Professional investors hold mixed...

    Read
  • A snapshot of hot biotech in Latin America

    A snapshot of hot biotech in Latin America

    According to a report from Deloitte, healthcare spending in Latin America is projected to increase 4.6 percent on average annually between 2014 and 2018, as pharmaceutical spending grows an...

    Read
  • loading
    Loading More...